Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress by Yacoub, S et al.
RESEARCH ARTICLE
Cardio-haemodynamic assessment and
venous lactate in severe dengue: Relationship
with recurrent shock and respiratory distress
Sophie Yacoub1,2*, Trieu Huynh Trung3, Phung Khanh Lam1, Vuong Huynh Ngoc Thien3,
Duong Ha Thi Hai3, Tu Qui Phan3, Oanh Pham Kieu Nguyet3, Nguyen Than Ha Quyen1,
Cameron Paul Simmons1,4, Christopher Broyd5, Gavin Robert Screaton2, Bridget Wills1,6
1 Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City,
Vietnam, 2 Department of Medicine, Imperial College London, London, United Kingdom, 3 Intensive Care
Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, 4 Department of Microbiology and
Immunology, University of Melbourne, Melbourne, Australia, 5 Faculty of Medicine, National Heart and Lung
Institute, Imperial College London, London, United Kingdom, 6 Nuffield Department of Medicine, University of
Oxford, Oxford, United Kingdom
* s.yacoub@imperial.ac.uk
Abstract
Background
Dengue can cause plasma leakage that may lead to dengue shock syndrome (DSS). In
approximately 30% of DSS cases, recurrent episodes of shock occur. These patients have
a higher risk of fluid overload, respiratory distress and poor outcomes. We investigated the
association of echocardiographically-derived cardiac function and intravascular volume
parameters plus lactate levels, with the outcomes of recurrent shock and respiratory distress
in severe dengue.
Methods/Principle findings
We performed a prospective observational study in Paediatric and adult ICU, at the Hospital
for Tropical Diseases (HTD), Ho Chi Minh City, Vietnam. Patients with dengue were enrolled
within 12 hours of admission to paediatric or adult ICU. A haemodynamic assessment and
portable echocardiograms were carried out daily for 5 days from enrolment and all interven-
tions recorded.
102 patients were enrolled; 22 patients did not develop DSS, 48 had a single episode of
shock and 32 had recurrent shock. Patients with recurrent shock had a higher enrolment
pulse than those with 1 episode or no shock (median: 114 vs. 100 vs. 100 b/min, P = 0.002),
significantly lower Stroke Volume Index (SVI), (median: 21.6 vs. 22.8 vs. 26.8mls/m2,
P<0.001) and higher lactate levels (4.2 vs. 2.9 vs. 2.2 mmol/l, P = 0.001). Higher SVI and
worse left ventricular function (higher Left Myocardial Performance Index) on study days
3–5 was associated with the secondary endpoint of respiratory distress. There was an asso-
ciation between the total IV fluid administered during the ICU admission and respiratory dis-
tress (OR: 1.03, 95% CI 1.01–1.06, P = 0.001). Admission lactate levels predicted patients
who subsequently developed recurrent shock (P = 0.004), and correlated positively with the
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total IV fluid volume received (rho: 0.323, P = 0.001) and also with admission ALT (rho:
0.764, P<0.001) and AST (rho: 0.773, P<0.001).
Conclusions/Significance
Echo-derived intravascular volume assessment and venous lactate levels can help identify
dengue patients at high risk of recurrent shock and respiratory distress in ICU. These find-
ings may serve to, not only assist in the management of DSS patients, but also these hae-
modynamic endpoints could be used in future dengue fluid intervention trials.
Author summary
Dengue is a viral illness that can lead to severe and potentially fatal complications. The
most common complication is fluid leakage from blood vessels, which can cause low
blood pressure or dengue shock syndrome (DSS). The majority of patients recover with
simple intravenous fluid replacement, however in approximately 30% of DSS cases, recur-
rent episodes of shock occur, and these patients have a higher risk of fluid overload, respi-
ratory distress and death. We investigated whether using portable echocardiograms
(Echo) in the intensive care unit (ICU) to assess cardiac function and intravascular vol-
ume parameters as well as blood lactate levels, can help identify these patients. We found
patients who developed recurrent shock had higher heart rates and lower Stroke Volume
Index (SVI), and higher lactate levels at enrolment than those with 1 episode or no shock.
Higher SVI and worse cardiac function after 3 days in ICU was associated with respiratory
distress. Admission lactate levels predicted patients who subsequently developed recurrent
shock and correlated positively with the total IV fluid volume received. These results dem-
onstrate that Echo-derived intravascular volume assessment and venous lactate levels can
help identify dengue patients at high risk of poor outcomes in the ICU, and could assist in
the management of severe dengue.
Introduction
Dengue is a flaviviral infection that causes substantial morbidity in endemic areas, with 96 mil-
lion clinically apparent cases each year [1]. Although the majority of infections result in a self-
limiting febrile illness, 1–5% of cases can experience more severe manifestations, in the form
of organ impairment, coagulopathy and plasma leakage which may lead to intravascular vol-
ume depletion and dengue shock syndrome (DSS). The plasma leakage usually resolves around
defervescence, and the extravasated fluid then gets reabsorbed, when fluid overload in the
form of massive pleural effusions or pulmonary oedema can occur. The resulting respiratory
compromise has been associated with an increased risk of death in adult [2] and paediatric
severe dengue [3]. The current treatment of DSS is supportive, with careful intravenous fluid
replacement. The majority of patients recover after a single crystalloid bolus and in experi-
enced centres the mortality rate is less than 1% [4]. However, in approximately 30% of DSS
cases, recurrent episodes of shock occur, which require more intensive treatment with larger
volumes of intravenous fluids including colloid boluses; these patients have a higher risk of
fluid overload, respiratory distress and poor outcomes [5]. Identifying such individuals early
and investigating other potential contributing factors for recurrent shock is needed. Although
the main mechanism of DSS is hypovolaemia, it is becoming increasingly recognized that
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myocardial impairment may play a role in the haemodynamic instability and potentially could
contribute to recurrent shock [6, 7]. Cardiac manifestations of dengue are diverse and include
functional myocardial impairment, arrhythmias and myocarditis, however the clinical signifi-
cance of these in DSS has not been well studied [8].
We have shown previously that systemic microvascular dysfunction occurs in more severe
dengue infections, but the effect on end-organ perfusion has not been evaluated [9]. Lactate
levels can be representative of tissue perfusion and elevated levels are associated with organ
failure and predict mortality in septic shock [10, 11]. Serum lactate levels and their prognostic
significance in dengue shock syndrome have only been evaluated in small studies and in adults
[12–14].
In this study we investigated the association of echocardiographically-derived cardiac func-
tion and intravascular volume parameters as well as lactate levels with the clinical outcomes of
recurrent shock and respiratory distress in adults and children admitted to ICU with dengue.
We hypothesised that DSS patients with cardiac dysfunction and elevated lactate levels would
be more likely to develop recurrent shock and also to experience iatrogenic fluid overload and
respiratory distress.
Methods
This prospective observational study was performed at the Hospital for Tropical Diseases
(HTD), Ho Chi Minh City, Vietnam. Individuals aged above 3 years were screened for enrol-
ment if they were admitted to either paediatric or adult Intensive Care Unit (ICU) with a clini-
cal diagnosis of dengue with warning signs or severe dengue [15], and were within 12 hours
from ICU admission. In Vietnam patients aged 15 or more are admitted to adult ICU. All
patients were reviewed daily until hospital discharge or for up to 5 days from enrolment; at
each assessment standardized clinical information was recorded including clinical symptoms
and signs, vital signs and all interventions. The amount and type of all intravenous fluids were
documented. Portable echocardiograms were performed as soon as feasible after enrolment,
and then daily until discharge from ICU. The patients were followed up 10–14 days later.
Ethics statement
Ethical approvals were obtained from the Oxford Tropical Research Ethics Committee and the
Ethics Review Committee at HTD, and written informed consent was obtained from all partic-
ipants or the parent/guardian of children.
Laboratory parameters
A full blood count was performed daily and at follow-up. A biochemistry sample for liver and
renal function was performed at enrolment and subsequently depending on clinical need. An
un-cuffed venous blood sample was taken at enrolment for venous lactate which was processed
within 30 minutes of collection.
Dengue diagnostics: Commercial IgM and IgG serology assays (Capture ELISA, Panbio,
Australia) were performed on batched acute and convalescent plasma. In addition RT-PCR
was performed on the enrolment sample to identify the DENV serotype and measure plasma
viraemia levels [16]. Patients were defined as having dengue if the RT-PCR was positive or if
the IgM assays were positive at enrolment, or IgM seroconversion between paired specimens
and on the basis of their clinical picture. Patients with negative tests at enrolment, but for
whom convalescent plasma was not available, were considered unclassifiable.
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Portable echocardiograms
Echocardiograms were performed at the bedside by one of the investigators (SY, HT, VN), using
an M-turbo system (FUJIFILM SonoSite, Inc, USA) with cardiac settings. The Echocardiograms
were performed daily and at follow-up 14 days later. The exam included two-dimensional, M-
mode and Doppler studies. More detailed methodology can be found elsewhere [6]. All images
were stored digitally and a selection reviewed by a cardiologist (CB) in the United Kingdom. The
inter- and intra- user variability was checked at regular intervals and was consistently<10%.
Statistical analysis and endpoint definitions
Endpoints. The primary endpoint was recurrent shock, which was defined as occurrence
of more than one episode of clinical shock during the ICU admission. Shock episodes were
recorded by the study doctors each day using the following definition; hypotension for age or
pulse pressure of 20 mmHg or less with signs of circulatory compromise, requiring additional
fluid bolus administration or refractory shock, requiring additional inotropic support. The sec-
ondary endpoint was respiratory distress, defined as the need for oxygen therapy or respiratory
support. Cardiac dysfunction was defined as an ejection fraction <55% and/or left/right myo-
cardial performance index (L/RMPI >0.5).
Statistical analysis
Linear regression models were used for the initial analysis, with each cardio-haemodynamic
parameter as the outcome and shock status as covariate. The analysis was adjusted for age, gen-
der, and day of illness at ICU admission. Logistic regression was used for the prognostic mod-
els, predefined candidate variables at enrolment were used to predict recurrent shock/
respiratory distress. Associations between the parameters were assessed by partial correlations
controlling for the following potential confounding variables: age, sex and day of illness at
enrolment, study day of measurement. Significance of partial correlations was assessed based
on their Fisher transformation and corresponding bootstrap standard errors. The cluster boot-
strap which resamples patients rather than samples accounted for multiple measurements per
patient. To informally adjust for multiplicity, a significance level of 0.01 was used for all com-
parisons. All analyses were performed with the statistical software R version 3.2.2 and the com-
panion package geepack version 1.2–0.
Results
One hundred and three patients were enrolled between September 2014 and September 2015,
1 patient was excluded from the analysis due to an inconclusive diagnosis and 88 had serial
echocardiograms (S1 Fig). The median age was 11 years (IQR 8–14 years). The median time
from ICU admission to enrolment was 0.1 hours (IQR: 0.0–1.0 hour), and from enrolment to
first echo was 2.5 hours (IQR 1.0–9.3 hours). Twenty-two patients did not develop DSS, 80
patients had DSS, of which 48 had a single episode and 32 had recurrent episodes of shock (4
of these 32 patients required inotropes for refractory shock). Of the patients with 1 episode of
shock 34/48 had shock at ICU admission and 14/48 developed shock; median time of 1.75
hours (IQR: 0.75–4.08 hours) after admission. The patients with recurrent shock, 27/32 had
shock at ICU admission and 5/32 developed their first episode of shock; median of 1.92 hours,
(0.06–6.88 hrs) after admission. The patients who were not in shock at ICU admission, were
admitted for more intensive monitoring and/or fluid therapy due to the presence of several
warning signs. Nineteen patients developed the secondary endpoint of respiratory distress, 10
(53%) on day 2, 8 (42%) on day 3 and 1 (5%) on day 4, all had radiological evidence of pleural
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effusions but not pulmonary oedma (S1A Fig). Seven patients had major bleeding, all following
shock, 6/7 with recurrent shock and 1/7 with 1 episode of shock. Of the 97 patients for whom
RT-PCR was performed, 65 were positive with the following serotypes: 52 DENV-1 (80%); 10
DENV-2 (15%; and 3 DENV-4 (5%). There was 1 death in the study population in adult ICU.
63/102 (62%) were admitted to ICU straight from clinic/community, 39/102 were admitted
from the general ward, after a median of 22 hours, but no intravenous fluids were administered
on the general wards.
At enrolment, platelet counts and albumin levels were significantly lower, and AST levels signif-
icantly higher, in patients who later experienced recurrent shock than those who did not. Lactate
levels were also significantly higher in patients who went on to have recurrent episodes of shock
than those who had 1 episode or no shock (Table 1). Hyperlactatemia, using a cut-off of>4 mmol/
l, was present in 17/32 (53.1%) of the individuals with recurrent shock, 8/48 (16.7%) of the patients
with 1 shock episode and was absent in all patients without shock. Considering the 88 patients that
had serial echocardiograms, 24/88 (27%) had evidence of left ventricular dysfunction and 6/8 (7%)
right ventricular dysfunction. A higher proportion of adults had left and right ventricular dysfunc-
tion, 11/16 (69%) and 4/16 (25%) compared to children, 13/72 (18%) and 2/72 (3%).
Enrollment cardio-haemodynamic parameters
Patients who developed recurrent shock had a higher enrolment pulse than those with 1 epi-
sode of shock or no shock (median: 114 vs. 100 vs. 100 b/min, P = 0.002), and reduced pulse
pressure (PP) (median: 20 vs. 20 vs. 30 mmHg, P = 0.001) (Table 2). There was a significantly
lower Stroke Volume Index (SVI) in the patients with recurrent shock versus patients with
and without 1 shock (median: 21.6 vs. 22.8 vs. 26.8ml/m2, P = 0.002).
Table 1. Enrollment characteristics for dengue patients in ICU.
All patients
(n = 102)
No shock
(n = 22)
Shock
(n = 48)
Recurrent shock
(n = 32)
p
Characteristic n n n n
Age (yrs) 102 11 (8, 14) 22 12 (10, 20) 48 11 (8, 14) 32 10 (8, 13) 0.583
Female 102 48 (47.1%) 22 11 (50.0%) 48 22 (45.8%) 32 15 (46.9%) 0.966
Illness day 102 6 (5, 6) 22 6 (5, 6) 48 6 (5, 6) 32 6 (5, 6) 0.237
Platelets (109/L) 99 29(18, 41) 22 37 (30, 62) 46 28 (19, 40) 31 27 (15, 33) 0.011
White cells (109/L) 99 4.6 (3.0, 5.8) 22 4.9 (3.4, 5.8) 46 4.6 (3.0, 6.3) 31 3.4 (3.0, 5.6) 0.695
HCT (%) 98 44.6 (41.6,48.6) 22 42.0 (40.7, 45.6) 45 44.7 (42.5, 48.8) 31 46.6 (41.5, 50.0) 0.076
Albumin(g/L) 98 33.5 (29.2, 37.3) 22 38.0 (33.3, 41.0) 46 33.5 (29.4, 37.0) 30 30.1 (23.6,34.8) <0.001
AST(U/L) 92 164 (104, 343) 20 102 (80, 162) 45 217 (106, 384) 27 219 (129, 540) 0.001
ALT(U/L) 92 86 (41–161) 20 63 (32–96) 45 98 (46–160) 27 112 (45–266) 0.041
Lactate (mmol/l) 98 2.9 (2.2, 3.9) 22 2.2 (2.0, 2.7) 46 2.9 (2.2, 3.6) 30 4.2 (2.6, 4.7) <0.001
Fluid accumulation 102 64 (62.7%) 22 5 (22.7%) 48 31 (64.6%) 32 28 (87.5%) <0.001
Outcomes
Total IV Fluid 84 3155 (1845, 5211) 5 0 (0, 0) 47 3020 (2198, 4337) 32 5876 (4257, 7300) <0.001
Colloid bolus 102 30 (35.7%) 22 0 (0.0%) 47 5 (10.6%) 32 25 (78.1%) <0.001
>1 Colloid bolus 102 19 (18.6%) 22 0 (0.0%) 48 0 (0.0%) 32 19 (59.4%)
Respiratory Distress 102 19 (18.6%) 22 0 (0.0%) 48 4 (8.3%) 32 15 (46.9%) <0.001
Inotropes 102 4 (3.9%) 22 0 (0.0%) 48 0 (0.0%) 32 4 (12.5%) 0.010
Data is presented as absolute count (%) for categorical variables and median (IQR) for continuous data. P-values are based on Kruskal-Wallis (continuous
data) and Fisher’s exact test (categorical data).
Fluid accumulation: Clinical pleural effusion and/or ascites
https://doi.org/10.1371/journal.pntd.0005740.t001
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Association of cardio-haemodynamic parameters with shock status over
ICU admission
SVI was significantly lower at enrolment (study day 1) for patients with recurrent shock com-
pared with no shock (median: 21.6 vs. 26.8mls/m2, P<0.001) and also between patients with
shock compared with no shock (median: 22.8 vs. 26.8mls/m2, P = 0.001) (Table 3, Fig 1).
There was a significantly lower cardiac index (CI) between patients with shock compared
to no shock on the first study day. The SVI remained lower for patients with recurrent shock
versus no shock on study day 2 (median: 22.8 vs. 27.2 mls/m2, P = 0.004). A non-significant
trend for higher CI and LMPI was observed on study day 3 in the recurrent shock patients
compared to no shock.
Association of cardio-haemodynamic parameters and respiratory
distress over ICU admission
Higher SVI on study day 4 was associated with the secondary endpoint of respiratory distress,
as well as a trend for higher CI and respiratory distress (S1 Table). The majority of patients
only received IV fluids on days 1–2 days (S2 Table), so the higher SVI on days 4 and 5 likely
represents fluid re-absorption rather than iatrogenic causes. On study days 3–5, worse left
ventricular function (higher LMPI) was associated with respiratory distress. There was an asso-
ciation between the total IV fluid administered during the ICU admission and respiratory dis-
tress (OR: 1.03, 95% CI 1.01–1.06, P = 0.001). Respiratory distress presented early (study day
2) in half of the patients, all had evidence of bilateral pleural effusions, suggesting plasma leak-
age likely causes early respiratory distress in ICU which is later compounded by fluid re-
absorption and myocardial impairment on study days 3–5.
Prognostic value of cardio-haemodynamics and laboratory variables for
recurrent shock and respiratory distress
Enrolment lactate levels predicted patients who subsequently developed recurrent shock com-
pared to those who did not (Table 4). In addition, higher enrolment lactate levels were also
found to predict patients developing respiratory distress (3.9 vs. 3.0 mmol/l, OR 1.46, 95% CI
1.09–2.12, P = 0.008).
Table 2. Enrollment cardiac function and Haemodynamics in dengue patients on admission to the Intensive Care Unit.
n
All patients
(N = 102) n
No shock
(N = 22) n
Shock
(N = 48) n
Recurrent shock
(N = 32)
p
Pulse (b/min) 102 101 (92, 120) 22 100 (80, 106) 48 100 (92, 114) 32 114 (100, 130) 0.003
MAP (mmHg) 102 83 (77, 87) 22 73 (72, 80) 48 80 (73, 88) 32 80 (70, 86) 0.506
PP (mmHg) 102 20 (20, 30) 22 30 (30, 40) 48 20 (20, 30) 32 20 (15, 20) <0.001
SVI (ml/m2) 68 22.6 (20.1, 25.3) 14 26.8 (23.2, 28.4) 32 22.8 (20.6, 25.3) 22 21.6 (19.4, 23.0) 0.002
CI (L/min/m2) 68 2.2 (1.9, 2.5) 14 2.3 (2.2, 2.7) 32 2.0 (1.8, 2.3) 22 2.2 (2.0, 2.5) 0.035
IVCCI 64 0.39 (0.34, 0.48) 13 0.37 (0.31, 0.40) 32 0.40 (0.35, 0.49) 19 0.40 (0.35, 0.47) 0.323
LVDd (cm) 68 3.7 (3.3, 4.0) 14 3.6 (3.3, 4.2) 32 3.7 (3.3, 4.0) 22 3.5 (3.3, 3.9) 0.914
EF (%) 68 66.3 (61.9, 69.0) 14 66.8 (61.7, 69.0) 32 66.7 (62.9, 69.6) 22 65.8 (60.7, 68.1) 0.711
LMPI 68 0.36 (0.27, 0.48) 14 0.36 (0.27, 0.50) 32 0.41 (0.26, 0.48) 22 0.34 (0.28, 0.41) 0.942
RMPI 66 0.18 (0.12, 0.26) 14 0.14 (0.12, 0.21) 32 0.18 (0.12, 027) 20 0.18 (0.12, 0.26) 0.278
Data is presented as absolute count (%) for categorical variables and median (IQR) for continuous data. P-values are based on Kruskal-Wallis (continuous
data) and Fisher’s exact test (categorical data).
https://doi.org/10.1371/journal.pntd.0005740.t002
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Table 3. Cardio-haemodynamic variables in patients with and without shock and recurrent shock, over ICU admission.
No shock Shock Recurrent
shock
Recurrent shock vs.
shock
Recurrent shock vs.
no shock
n n n Effect 95% CI p Effect 95% CI p
SVI ml/m2
Day 1 14 26.8 (23.2,
28.4)
32 22.8 (20.6,
25.3)
22 21.6 (19.4,
23.0)
-1.25 (-3.09, 0.60) 0.185 -4.63 (-6.89, -2.36) <0.001
Day 2 16 27.2 (24.1,
29.3)
34 27.1 (21.0,
29.4)
22 22.8 (20.6,
24.3)
-3.00 (-5.50, -0.50) 0.019 -4.34 (-7.30, -1.38) 0.004
Day 3 15 28.9 (24.2,
30.7)
34 29.5 (26.1,
32.8)
16 27.0 (23.0,
31.7)
-2.14 (-4.67, 0.39) 0.098 0.06 (-2.89, 3.02) 0.967
Day 4 2 29.4 (29.0,
29.7)
17 30.3 (27.7,
34.8)
17 32.1 (29.2,
35.4)
1.84 (-1.11, 4.79) 0.221 3.17 (-3.10, 9.43) 0.322
Day 5 2 31.2 (29.7,
32.8)
4 29.4 (28.0,
31.5)
8 34.8 (31.9,
37.6)
4.20 (-0.63, 9.03) 0.088 -1.64 (-16.68, 13.4) 0.831
>Day 13 14 32.2 (31.2,
33.0)
32 31.4 (29.5,
33.5)
22 31.1 (29.3,
32.2)
CI l/min/m2
Day 1 14 2.3 (2.2,
2.7)
32 2.0 (1.8, 2.3) 22 2.2 (2.0, 2.5) 0.21 (0.00, 0.42) 0.053 -0.18 (-0.44, 0.08) 0.172
Day 2 16 2.4 (2.2,
2.5)
34 2.2 (1.9, 2.5) 22 2.2 (2.0, 2.3) -0.01 (-0.25, 0.22) 0.923 -0.17 (-0.44, 0.11) 0.236
Day 3 15 2.4 (2.1,
2.5)
34 2.5 (2.2, 2.7) 16 2.7 (2.3, 3.0) 0.17 (-0.08, 0.41) 0.176 0.34 (0.06, 0.62) 0.019
Day 4 2 2.4 (2.3,
2.4)
17 2.6 (2.2, 2.9) 17 3.0 (2.7, 3.1) 0.42 (0.03, 0.80) 0.037 0.64 (-0.19, 1.46) 0.130
Day 5 2 2.4 (2.3,
2.5)
4 2.5 (2.2, 2.8) 8 3.0 (2.5, 3.2) 0.08 (-0.35, 0.52) 0.699 -1.22 (-2.56, 0.12) 0.075
>Day13 14 2.8 (2.6,
2.9)
31 2.8 (2.6, 2.8) 22 2.7 (2.6, 2.9)
LMPI
Day 1 14 0.36 (0.27,
0.50)
32 0.42 (0.26,
0.48)
22 0.34 (0.28,
0.41)
0.00 (-0.08, 0.07) 0.951 0.02 (-0.08, 0.11) 0.742
Day 2 14 0.37 (0.30,
0.44)
26 0.37 (0.30,
0.48)
17 0.37 (0.26,
0.51)
0.01 (-0.08, 0.09) 0.888 0.02 (-0.08, 0.12) 0.752
Day 3 14 0.28 (0.20,
0.36)
26 0.35 (0.27,
0.43)
16 0.34 (0.25,
0.45)
-0.01 (-0.09, 0.08) 0.852 0.08 (-0.01, 0.18) 0.085
Day 4 2 0.30 (0.26,
0.33)
15 0.36 (0.32,
0.46)
16 0.42 (0.31,
0.51)
0.03 (-0.05, 0.11) 0.448 0.09 (-0.08, 0.26) 0.300
Day 5 2 0.33 (0.36,
0.37)
4 0.23 (0.21,
0.28)
8 0.31 (0.29,
0.35)
0.05 (-0.02, 0.13) 0.169 -0.09 (-0.32, 0.15) 0.465
>Day13 14 0.17 (0.11,
0.23)
31 0.20 (0.18,
0.23)
22 0.21 (0.19,
0.24)
IVCCI
Day 1 13 0.37 (0.31,
0.40)
32 0.40 (0.35,
0.49)
19 0.40 (0.35,
0.47)
-0.01 (-0.07, 0.05) 0.802 0.05 (-0.03, 0.12) 0.222
Day 2 14 0.31 (0.25,
0.36)
33 0.33 (0.28,
0.36)
19 0.31 (0.30,
0.37)
0.01 (-0.04, 0.06) 0.826 0.03 (-0.03, 0.09) 0.285
Day 3 15 0.29 (0.23,
0.33)
33 0.24 (0.20,
0.30)
16 0.28 (0.25,
0.32)
0.04 (0.00, 0.09) 0.067 0.01 (-0.04, 0.07) 0.601
Day 4 2 0.28 (0.25,
0.31)
18 0.23 (0.21,
0.27)
17 0.24 (0.21,
0.26)
0.00 (-0.04, 0.04) 0.902 -0.04 (-0.12, 0.05) 0.397
Day 5 2 0.22 (0.22,
0.22)
4 0.20 (0.17,
0.23)
8 0.22 (0.21,
0.25)
0.02 (-0.03, 0.07) 0.429 -0.05 (-0.21, 0.10) 0.508
(Continued )
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Correlation of cardio-haemodynamic variables and lactate levels
The SVI correlated with other parameters of intravascular volume including inferior vena cava
collapsibility index (IVCCI) with a negative correlation (rho -0.491, P<0.001) and left ventric-
ular end-diastolic diameter (LVEDD) with a positive correlation (rho 0.354, P<0.001). The
IVCCI correlated with LMPI with a positive correlation (rho 0.230, P<0.001). The LMPI,
RMPI, LVEDD and IVCCI did not correlate with the amount of IV fluids in the preceding 24
hours.
Enrolment lactate levels correlated positively with the total IV fluid volume received (rho:
0.323, P = 0.001) and also with enrolment ALT (rho: 0.764, P<0.001) and AST (rho: 0.773,
P<0.001), but not with any of the cardio-haemodynamic parameters.
Table 3. (Continued)
No shock Shock Recurrent
shock
Recurrent shock vs.
shock
Recurrent shock vs.
no shock
n n n Effect 95% CI p Effect 95% CI p
>Day13 14 0.22 (0.15,
0.23)
32 0.21 (0.18,
0.23)
22 0.20 (0.18,
0.24)
Data is presented as median (IQR). Each row corresponds to comparison of each variable by admission day based on linear regression, with adjustment for
age, sex, day of illness at enrolment. Effect (and 95%CI, p) corresponds to mean difference in variable of interest between recurrent shock and shock and
also recurrent shock and no shock. Day = study day, SVI = Stroke Volume Index, CI = Cardiac Index, LMPI = Left Myocardial Performance Index,
IVCCI = Inferior Vena Cava collapsibility Index.
Using linear regression there was a significant trend test for SVI between the shock groups on day 1 (P<0.001) and day2 (P = 0.003).
https://doi.org/10.1371/journal.pntd.0005740.t003
Fig 1. “Stroke Volume Index over ICU admission in patients with no shock, shock and recurrent shock.” Graph showing the dynamics of SVI by
study day for 87 patients. Grey lines are changes of SVI for each patient. Colored lines connect medians of SVI on each study day for each patient group.
https://doi.org/10.1371/journal.pntd.0005740.g001
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Discussion
We have shown that myocardial impairment was not associated with recurrent shock but was
associated with the secondary endpoint of respiratory distress after 3 days of the ICU admis-
sion. Lower stroke volume indices during the first 2 days of ICU admission and tachycardia
were associated with both recurrent shock and respiratory distress. Higher lactate levels at ICU
admission were also predictive for recurrent shock and respiratory distress. These results sug-
gest patients with evidence of severe volume depletion at ICU admission including lower SVI,
higher heart rates and venous lactates were more likely to develop recurrent shock and require
more intravenous fluids–resulting in respiratory distress from a combination of plasma leak-
age and myocardial impairment, exacerbated by volume overload from fluid reabsorption in
the recovery phase.
Cardiac functional assessment in patients with hypovolaemia is more challenging and
hence our use of Doppler derived parameters, which have been shown to be less preload
dependent [17]. Myocardial dysfunction was associated with respiratory distress but not with
recurrent shock, suggesting the myocardial impairment was sufficient to play a role in fluid
overload, following resuscitation and the associated respiratory compromise but not to con-
tribute to the shock syndrome, which appears to be driven predominantly by intravascular vol-
ume depletion. These findings are comparable to other echo studies, including one study of
Thai children which demonstrated 36% of patients with DSS had reduced systolic function
and patients with cardiac impairment were more likely to have fluid overload [18]. The mecha-
nisms underlying this transient myocardial dysfunction in dengue patients remain to be
defined, but potential mechanisms may involve some or a combination of the following; myo-
cardial depressant factors, myocardial interstitial oedema, abnormal coronary microcircula-
tion and endothelial dysfunction and also abnormal calcium homeostasis [8, 19, 20].
Most patients admitted to ICU with severe dengue showed signs of intravascular volume
depletion, as evidenced by low SVI, CI, and smaller LVEDD and higher IVCCI compared to
follow-up. Ejection fractions however remained normal in all the groups, which may be
explained by low end diastolic volume and/or diastolic dysfunction- both which may play a
role in dengue. SVI was the most robust parameter associated with the severe outcomes of
recurrent shock and respiratory distress. Heart rate was significantly higher at enrolment
between patients with recurrent shock versus no shock. This confirms a previous study where
higher heart rate was found to be useful in predicting children developing profound shock
Table 4. Enrollment cardio-haemodynamic and laboratory variables for predicting recurrent shock.
n One episode Shock
(n = 48)
n Recurrent Shock
(n = 32)
OR (95% CI) p value
SVI ml/m2 32 22.8 (20.6, 25.3) 22 21.6 (19.4, 23.0) 0.88 (0.73, 1.05) 0.173
CI l/min/m2 32 2.0 (1.8, 2.3) 22 2.2 (2.0, 2.5) 6.31 (1.21, 40.97) 0.028
LMPI 32 0.41 (0.26, 0.48) 22 0.34 (0.28, 0.41) 0.77 (0.01, 56.19) 0.906
RMPI 32 0.2 (0.1, 0.3) 19 0.2 (0.1, 0.3) 0.73 (0.00, 175.70) 0.910
IVCCI 32 0.40 (0.35, 0.49) 19 0.40 (0.35, 0.47) 1.97 (0.00, 1014.93) 0.828
HCT (%) 45 44.7 (42.5, 48.8) 31 46.6 (41.5,50.0) 1.04 (0.95, 1.15) 0.405
PLT (109/L) 46 28 (19, 41) 31 27 (15, 33) 0.99 (0.97,1.01) 0.534
Lactate (mmol/l) 46 2.9 (2.2, 3.6) 30 4.2 (2.6, 4.7) 1.46 (1.11, 2.07) 0.004
Log2Lactate 46 1.6 (1.1, 1.9) 30 2.1 (1.4, 2.2) 2.71 (1.29, 6.41) 0.008
Data are presented as absolute count (%) for categorical variables and median (IQR) for continuous data. All analyses were based on univariate logistic
regression model, adjusted for age, sex, illness day at enrolment.
https://doi.org/10.1371/journal.pntd.0005740.t004
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[21]. The IVCCI, although being higher in patients at enrolment compared to discharge, did
not discriminate between shock and no shock and was not associated with clinical outcomes.
IVCCI has also been shown to correlate with central venous pressure (CVP) and right atrial
pressure (RAP) in children and adults [22, 23], and is useful in predicting fluid responsiveness,
in mechanically ventilated patients and in spontaneously breathing patients [24, 25]. Due to
the coagulopathy and thrombocytopenia in the majority of severe dengue patients, CVP car-
ries a significant risk of bleeding and other non-invasive methods of assessing intravascular
volume and guiding fluid therapy are urgently needed [26]. Portable bedside echocardio-
graphic assessment of haemodynamics, particularly the SVI are useful in identifying patients
with recurrent shock and could be considered as an alternative to invasive CVP monitoring.
We have shown venous lactates in dengue patients on the first day of admission to ICU is
associated with severe outcomes of recurrent shock and respiratory distress. Lactate levels cor-
related with the total amount of IV fluids received, but did not correlate with other haemody-
namic parameters.
The higher lactates likely represent severe volume depletion from plasma leakage causing
tissue hypoperfusion, hypoxia and anaerobic glycolysis. In addition to hypoperfusion and
excess production of lactate, another mechanism for hyperlactatemia in severe dengue may
involve reduced hepatic clearance as moderate hepatic dysfunction occurs in severe dengue
[27]. The liver may play a role in the hyperlactatemia in critical illness with circulatory failure,
not only by reduced metabolism but also because the liver itself can produce lactate due to
hepatic ischaemia. This is supported by our study which showed lactate levels correlated posi-
tively with both ALT and AST levels.
A study investigating patients with shock admitted to ICU, found higher lactate levels in
patients with early hepatic dysfunction compared to those with no hepatic dysfunction, inde-
pendent of haemodynamic severity parameters [28]. Altered microcirculation, which we have
shown is worse in dengue patients with more severe plasma leakage [9], may play a role in the
increased lactate levels, although further studies are required to link the microcirculatory per-
fusion abnormalities with higher lactate levels.
The current WHO guidelines for managing DSS recommend initial resuscitation with crys-
talloid fluids for compensated shock, followed by careful on-going assessment including serial
HCT measurements and close monitoring of vital signs. Reassessing patients in shock and
achieving predefined physiological targets has been a major focus of research in severe sepsis
in the last 2 decades [29–31]. The ‘goals’ of resuscitation are currently being readdressed with
emerging evidence that a conservative approach to fluid management has better outcomes in
certain settings [32]. The balance of administering just sufficient intravenous fluid therapy to
maintain haemodynamic stability while avoiding fluid overload and respiratory compromise
is extremely difficult and additional cardiovascular monitoring using portable echocardiogra-
phy in DSS would be beneficial. Stroke volume monitoring may provide improved targeted
volume resuscitation. While serial HCT and vital sign monitoring are useful and widely appli-
cable for resource constrained settings, intensive care facilities and associated technologies are
improving in many dengue endemic areas, so additional non-invasive cardiovascular assess-
ment is now possible and should be considered where available.
There were some limitations to our study. In order not to interfere with emergency man-
agement, some patients had the first echo study after initial fluid resuscitation had com-
menced. This may therefore underestimate some of the cardiovascular parameters. Secondly,
due to restrictions on research blood sampling in paediatric patients, we were unable to take
daily lactates so it was not possible to study lactate clearance times. In addition, due to the coa-
gulopathy in many of severe dengue patients, we were unable to take arterial blood gases for
assessment of metabolic acidosis to explore relationship with the high lactate levels. As the
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majority of patients enrolled in this study were children and young adults, the results may not
be generalizable to older adult populations with dengue.
Conclusion
In conclusion, this study has identified several simple non-invasive parameters that could
assist risk prediction and help tailor management of dengue patients admitted to ICU. We
have shown moderate cardiac dysfunction is common in ICU patients with dengue, particu-
larly among adults. The cardiac dysfunction does not appear to play a major part in the hae-
modynamic instability of dengue shock but likely contributes to the development of fluid
overload and respiratory compromise in some cases. Echo-derived volume assessment using
stroke volume index combined with heart rate monitoring and venous lactate levels can help
identify patients at high risk of recurrent shock. The clinical and therapeutic implications of
these findings are potentially important, first as prognostic markers to guide fluid resuscitation
and assist in the management of DSS as currently practiced, and second, these echo-derived
haemodynamic endpoints could be used in future dengue fluid intervention trials designed to
assess alternative strategies intended to improve DSS management and outcome.
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